Blis Technologies (NZX: BLT) has signed an agreement with a significant Australasian cosmetic skincare company to licence their facial live probiotic serum containing BLIS Q24®.
This agreement will allow the partner to exclusively market the serum formulation under their brand domestically and in export markets.
The new partnership is expected to have a positive impact on earnings in FY24 and solid growth in the following years.
See more
